News Release

International collaboration uncovers structure of Huntington’s disease protein

Peer-Reviewed Publication

University of Groningen

The structure of Huntington's fibrils

image: 

Visualization of the protein clumps associated with Huntington’s disease, determined by combining simulations and multiple complementary types of experiments. The figure shows the overall structure at the top, with aspects of the disordered surface (fuzzy coat, left) and the protected core (right) shown in detail below. This coat is targeted by other proteins in the cell. However, the findings in the study suggest that the fuzzy coat will resist these interactions, which has implications for our understanding of how these toxic proteins can be targeted for destruction.

view more 

Credit: Adapted from Bagherpoor Helabad, M. et al, Nature Communications.

Huntington’s disease (HD) is an inherited disorder in which the nerve cells in parts of the brain gradually break down and die. It is caused by a protein called huntingtin, which forms unnatural clumps as a result of a mutation.

However, until now it was unknown what these clumps exactly look like, unlike in other diseases caused by clumping of defective proteins, such as Alzheimer’s or Parkinson’s. An international team of scientists, including University of Groningen Professor of Solid State NMR Spectroscopy Patrick van der Wel, has used a combination of computer and experiment-based techniques to present the first detailed picture of these disease-related clumps. The study provides new insights into the ‘fuzzy coat’ that these clumps have on their surface.

Diagnostics and treatments       

Similar to the clumps in Alzheimer’s and Parkinson’s, the clumps in Huntington’s disease are elongated shapes called fibrils. However, the Huntington’s fibrils differ in important ways from those in other fibril-induced diseases.

‘Knowing the structure of the protein clump is a critical piece of the puzzle of how these proteins play their role in the disease,’ says Van der Wel. It also paves the way for developing diagnostics and perhaps even treatments. ‘It’s important to monitor the disease proteins in patients, for example during experimental treatments.’ The project was supported by Huntington’s disease foundations, which are largely funded by families of patients and the general public.

Reference: Mahdi Bagherpoor Helabad, Irina Matlahov, Raj Kumar, Jan O. Daldrop, Greeshma Jain, Markus Weingarth, Patrick C. A. van der Wel & Markus S. Miettinen: Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease. Nature Communications, 30 December 2024


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.